Results 151 to 160 of about 2,589,815 (356)

The α₁‐Adrenergic Receptor Antagonist, Doxazosin, Reduces Alcohol Drinking in Alcohol‐Preferring (P) Rats [PDF]

, 2012
Meghan L. O’Neil, Lauren E. Beckwith, Carrie Kincaid, Dennis D. Rasmussen   +3 more
openalex   +1 more source

Efficacy and Safety of Lisdexamfetamine Versus Topiramate Versus Naltrexone/Bupropion in Individuals With Binge Eating Disorder: A Network Meta‐Analysis

European Eating Disorders Review, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of lisdexamfetamine, topiramate, and naltrexone/bupropion for treating binge eating disorder (BED) using network meta‐analysis. Method We systematically searched PubMed, Scopus, ClinicalTrials.gov, and Cochrane Central up to February 2025 for randomized controlled trials evaluating these medications
Tamer Hodrob, Ibrahim Ismail, Alaaeddin Abusalameh, Celina R. Andonie, Omar Ayesh, Hazem Ayesh   +5 more
wiley   +1 more source

Combining theα₁-Adrenergic Receptor Antagonist, Prazosin, with theβ-Adrenergic Receptor Antagonist, Propranolol, Reduces Alcohol Drinking More Effectively Than Either Drug Alone

, 2014
Dennis D. Rasmussen, Lauren E. Beckwith, Carrie Kincaid, Janice C. Froehlich   +3 more
openalex   +2 more sources

Blockade of platelet alpha2B-adrenergic receptors in patients with coronary artery disease: a novel antiaggregant mechanism [PDF]

, 2013
Maria Marketou, George Kochiadakis, E. Kintsurasvili, Nikolaos Androulakis, Aikaterini Giaouzaki, Joanna Kontaraki, Michael G. Alexandrakis, Haralambos Gavras, Haralambos Gavras, Panos E. Vardas   +9 more
openalex   +1 more source

Activation of human brown adipose tissue by a β3-adrenergic receptor agonist.

Cell Metabolism, 2015
A. Cypess, Lauren S Weiner, C. Roberts-Toler, Elisa Franquet Elía, Skyler Kessler, Peter Kahn, Jeffrey English, K. Chatman, S. Trauger, Alessandro Doria, G. Kolodny   +10 more
semanticscholar   +1 more source

Alpha-1A adrenergic receptor activation increases inhibitory tone in CA1 hippocampus

, 2009
Kristin L. Hillman, Saobo Lei, Van A. Doze, James E. Porter   +3 more
openalex   +1 more source

Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling

Cell, 2015
A. Manglik, T. H. Kim, M. Masureel, C. Altenbach, Zhongyu Yang, D. Hilger, M. Lerch, T. S. Kobilka, Foon Sun Thian, Wayne L. Hubbell, R. S. Prosser, B. Kobilka   +11 more
semanticscholar   +1 more source

Nonlinear association of triglyceride‐glucose body mass index with all‐cause mortality in postmenopausal women, a retrospective cohort study: Evidence from the 2001 to 2014 National Health and nutrition examination survey

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background The triglyceride‐glucose body mass index (TyG‐BMI) is a novel indicator combining an insulin resistance proxy (TyG index) with adiposity. It remains unclear how TyG‐BMI relates to long‐term mortality risk in postmenopausal women, a group prone to metabolic changes after menopause.
Xiliang Wang, Kaiyue Wang, Chang Tan, Yuexin Yu   +3 more
wiley   +1 more source

Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells.

, 1992
Bernard Mouillac, M. Caron, H Bonin, Michael Dennis, Michel Bouvier   +4 more
openalex   +1 more source

A novel octopamine receptor with preferential expression in Drosophila mushroom bodies [PDF]

, 1998
Octopamine is a neuromodulator that mediates diverse physiological processes in invertebrates. In some insects, such as honeybees and fruit flies, octopamine has been shown to be a major stimulator of adenylyl cyclase and to function in associative ...
Han, K-A, Millar, NS
core